ACADIA Pharmaceuticals Inc.

DB:DR6 Stock Report

Market Cap: €2.2b

ACADIA Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

ACADIA Pharmaceuticals has a total shareholder equity of $516.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $914.1M and $397.4M respectively. ACADIA Pharmaceuticals's EBIT is $22.8M making its interest coverage ratio -1.1. It has cash and short-term investments of $500.9M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio-1.1x
CashUS$500.94m
EquityUS$516.70m
Total liabilitiesUS$397.40m
Total assetsUS$914.10m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: DR6's short term assets ($728.9M) exceed its short term liabilities ($337.9M).

Long Term Liabilities: DR6's short term assets ($728.9M) exceed its long term liabilities ($59.5M).


Debt to Equity History and Analysis

Debt Level: DR6 is debt free.

Reducing Debt: DR6 has not had any debt for past 5 years.

Debt Coverage: DR6 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: DR6 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies